DSM restructures pharma units in line with four year plan

Published: 21-Dec-2005

A pharma chemicals site in South Haven, Michigan, US, is to be closed and the a biopharma site in Montreal to be mothballed as DSM Pharmaceutical Products restructures its Pharma Chemicals and Biologics businesses. The changes form part of the New Jersey-based company's new strategy 'Vision 2010', announced in the third quarter of 2005.


A pharma chemicals site in South Haven, Michigan, US, is to be closed and the a biopharma site in Montreal to be mothballed as DSM Pharmaceutical Products restructures its Pharma Chemicals and Biologics businesses. The changes form part of the New Jersey-based company's new strategy 'Vision 2010', announced in the third quarter of 2005.

The DSM Pharma Chemicals operations in South Haven will stop in the first half of 2007, affecting 142 jobs. Ongoing activities will be absorbed in DSM Pharma Chemicals' Linz (Austria) and Venlo (the Netherlands) plants.

DSM plans to focus its pharmaceutical chemical operations on higher added value products, such as advanced and registered intermediates, APIs and more specialized generic APIs, as early stage intermediates will be sourced increasingly from China and India.

DSM Biologics will focus on the development of cell line technology rather than contract manufacturing. It has strengthened its alliance with Dutch biotech firm Crucell working in this field. DSM Biologics in Groningen, the Netherlands will, in addition to its contract manufacturing service, now provide full support to licensees of Crucell's PER.C6 technology. The facilities of DSM Biologics Montreal (Canada) will be mothballed in 2006 and 85 employees made redundant.

DSM expects its operating profit for 2005 to exceed €800m, compared with the previous year's €567m.

See more

You may also like

Manufacturing

Sapio Sciences introduces world’s first 3rd-generation ELN

Read more
Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Sapio Sciences introduces world’s first 3rd-generation ELN

Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
Research & Development

Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
Manufacturing

Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
Manufacturing

L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
Manufacturing

Limula partners with leading cancer centre to improve blood product processing for stem cell transplantation

The company will collaborate with Institut Paoli-Calmettes to advance haematopoietic stem cell (HSC) processing for transplants
Subscribe now